Cas 1622317-22-9,4-nitrophenyl 5-(6,7-dimethoxyquinazolin-4-yloxy)-4-fluoro-2-methyl-1H-indole-1-carboxylate

1622317-22-9

Post Buying Request

Basic information

Product Name: 4-nitrophenyl 5-(6,7-dimethoxyquinazolin-4-yloxy)-4-fluoro-2-methyl-1H-indole-1-carboxylate
Synonyms: 4-nitrophenyl 5-(6,7-dimethoxyquinazolin-4-yloxy)-4-fluoro-2-methyl-1H-indole-1-carboxylate
CAS NO:1622317-22-9
Molecular Formula:
Molecular Weight: 518.458
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4-nitrophenyl 5-(6,7-dimethoxyquinazolin-4-yloxy)-4-fluoro-2-methyl-1H-indole-1-carboxylate(CAS DataBase Reference)
NIST Chemistry Reference: 4-nitrophenyl 5-(6,7-dimethoxyquinazolin-4-yloxy)-4-fluoro-2-methyl-1H-indole-1-carboxylate(1622317-22-9)
EPA Substance Registry System: 4-nitrophenyl 5-(6,7-dimethoxyquinazolin-4-yloxy)-4-fluoro-2-methyl-1H-indole-1-carboxylate(1622317-22-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1622317-22-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1622317-22-9 Suppliers

Recommended suppliers

1622317-22-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1622317-22-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,6,2,2,3,1 and 7 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1622317-22:
(9*1)+(8*6)+(7*2)+(6*2)+(5*3)+(4*1)+(3*7)+(2*2)+(1*2)=129
129 % 10 = 9
So 1622317-22-9 is a valid CAS Registry Number.

1622317-22-9Upstream product

1622317-22-9Downstream Products

1622317-22-9Relevant academic research and scientific papers

THERAPEUTIC COMPOUNDS AND USES THEREOF

-

, (2014/09/03)

Described herein are compounds of Formula (I)-(III), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Also provided are particles (e.g., nanoparticles) comprising compounds of Formula (I)-(III) and pharmaceutical compositions thereof that are mucus penetrating. Methods of using the compounds or pharmaceutical compositions thereof for treating and/or preventing diseases are also provided.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1622317-22-9